课题基金 / 基金详情

SAFETY AND EFFICACY OF ZIDOVUDINE FOR ASYMPTOMATIC HIV INFECTED PEOPLE

SAFETY AND EFFICACY OF ZIDOVUDINE FOR ASYMPTOMATIC HIV INFECTED PEOPLE
齐多夫定对无症状 HIV 感染者的安全性和有效性
批准号：
3743611
负责人：
RONALD T. MITSUYASU
金额：
$0.0万
依托单位：
UNIVERSITY OF CALIFORNIA LOS ANGELES
依托单位国家：
美国
项目类别：
财政年份：
--
资助国家：
美国
项目状态：
未结题
起止时间：
至
来源：
https://reporter.nih.gov/project-details/3743611
关键词：
AIDS therapy HIV infections clinical trials dosage drug screening /evaluation human subject human therapy evaluation zidovudine

项目摘要

项目成果

RONALD T. MITSUYASU的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
This study seeks to determine the efficacy of zidovudine at a dose of 1500 mg per day or 500 mg per day compared to placebo, in HIV infected asymptomatic individuals with CD4 counts>500. Clinical efficacy is measured by a reduction in the incidence of symptoms of AIDS or AIDS related complex (ARC).
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Studies on the Prevalence, Risk Factors and Outcomes of Cancers in HIV in India
Studies on the Prevalence, Risk Factors and Outcomes of Cancers in HIV in India
South American Prevention of HIV Research Training Program (SAPHIR)
South American Prevention of HIV Research Training Program (SAPHIR)
海外基金